Dai-ichi Life Insurance Company’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.1M Sell
25,036
-5,965
-19% -$2.66M 0.31% 76
2025
Q1
$15M Sell
31,001
-923
-3% -$447K 0.44% 59
2024
Q4
$12.9M Buy
31,924
+5,831
+22% +$2.35M 0.36% 64
2024
Q3
$12.1M Sell
26,093
-4,219
-14% -$1.96M 0.31% 77
2024
Q2
$14.2M Sell
30,312
-24,362
-45% -$11.4M 0.35% 75
2024
Q1
$22.9M Sell
54,674
-17,546
-24% -$7.33M 0.52% 42
2023
Q4
$29.4M Buy
72,220
+11,394
+19% +$4.64M 0.61% 35
2023
Q3
$21.2M Hold
60,826
0.47% 45
2023
Q2
$21.4M Sell
60,826
-130
-0.2% -$45.7K 0.45% 50
2023
Q1
$19.2M Buy
60,956
+8,362
+16% +$2.63M 0.42% 50
2022
Q4
$15.2M Hold
52,594
0.35% 56
2022
Q3
$15.2M Sell
52,594
-260
-0.5% -$75.3K 0.38% 55
2022
Q2
$14.9M Sell
52,854
-49,593
-48% -$14M 0.33% 62
2022
Q1
$26.7M Buy
102,447
+43
+0% +$11.2K 0.43% 54
2021
Q4
$22.5M Sell
102,404
-18,000
-15% -$3.95M 0.29% 71
2021
Q3
$21.8M Buy
120,404
+4,057
+3% +$736K 0.28% 68
2021
Q2
$23.5M Buy
116,347
+30,000
+35% +$6.05M 0.29% 64
2021
Q1
$18.6M Sell
86,347
-5,493
-6% -$1.18M 0.26% 64
2020
Q4
$21.7M Buy
91,840
+27,623
+43% +$6.53M 0.31% 53
2020
Q3
$17.5M Buy
64,217
+8,726
+16% +$2.37M 0.31% 59
2020
Q2
$16.1M Buy
55,491
+33,965
+158% +$9.86M 0.37% 52
2020
Q1
$5.12M Buy
21,526
+1,359
+7% +$323K 0.2% 123
2019
Q4
$4.42M Buy
20,167
+41
+0.2% +$8.98K 0.1% 204
2019
Q3
$3.41M Hold
20,126
0.08% 242
2019
Q2
$3.69M Hold
20,126
0.09% 222
2019
Q1
$3.7M Hold
20,126
0.09% 225
2018
Q4
$3.34M Sell
20,126
-19
-0.1% -$3.15K 0.09% 226
2018
Q3
$3.88M Sell
20,145
-52,894
-72% -$10.2M 0.08% 226
2018
Q2
$12.4M Buy
73,039
+36,363
+99% +$6.18M 0.3% 80
2018
Q1
$5.98M Buy
36,676
+7,251
+25% +$1.18M 0.12% 163
2017
Q4
$4.41M Sell
29,425
-442
-1% -$66.2K 0.09% 201
2017
Q3
$4.54M Buy
29,867
+906
+3% +$138K 0.1% 201
2017
Q2
$3.73M Buy
28,961
+17,576
+154% +$2.26M 0.08% 222
2017
Q1
$1.25M Sell
11,385
-15,000
-57% -$1.64M 0.03% 354
2016
Q4
$1.94M Buy
+26,385
New +$1.94M 0.06% 301